Inventor
ZHANG HAIZHEN
CN21 patents
⚠️ This page may combine multiple inventors who share the name “ZHANG HAIZHEN”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
GASHERBRUM BIO INC
8 patentsUS11926626B2Mar 12, 2024
Heterocyclic GLP-1 agonists
GASHERBRUM BIO INC7 citations84
US11492365B2Nov 8, 2022
Heterocyclic GLP-1 agonists
GASHERBRUM BIO INC6 citations84
US12221442B2Feb 11, 2025
Heterocyclic GLP-1 agonists
GASHERBRUM BIO INC3 citations73
US11897851B2Feb 13, 2024
Heterocyclic GLP-1 agonists
GASHERBRUM BIO INC3 citations73
US12291529B2May 6, 2025
Heterocyclic GLP-1 agonists
GASHERBRUM BIO INC2 citations63
US12528781B2Jan 20, 2026
Heterocyclic GLP-1 agonists
GASHERBRUM BIO INC0 citations61
US11926643B2Mar 12, 2024
Heterocyclic GLP-1 agonists
GASHERBRUM BIO INC0 citations61
US12595264B2Apr 7, 2026
Heterocyclic GLP-1 agonists
GASHERBRUM BIO INC0 citations50
LILLY CO ELI
4 patentsUS11117891B2Sep 14, 2021
Isoquinolin and naphthydrin compounds
LILLY CO ELI0 citations62
US11214562B2Jan 4, 2022
Cyclohexyl benzamide compounds
LILLY CO ELI0 citations55
US10370352B2Aug 6, 2019
Cyclobutyl-imidazolidinone compounds
LILLY CO ELI0 citations49
US10196385B2Feb 5, 2019
Tetrahydropyranyl benzamide derivatives
LILLY CO ELI0 citations48